Natco Pharma Ltd (NATCOPHARM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies... Research Beam Model: Research Beam Product ID: 2135984 125 USD New
Natco Pharma Ltd (NATCOPHARM) - Financial and Strategic SWOT Analysis Review
 
 

Natco Pharma Ltd (NATCOPHARM) - Financial and Strategic SWOT Analysis Review

  • Category : Company Profiles
  • Published On : September   2017
  • Pages : 46
  • Publisher : GlobalData
 
 
 
Natco Pharma Ltd (NATCOPHARM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Natco Pharma Ltd (Natco Pharma) focuses on the research, development, manufacture and commercialization of pharmaceutical substances and finished dosage forms. The company offers finished dosage forms in capsule, injection and tablet. Its products are indicated to treat multiple sclerosis, influenza infection, multiple myeloma, leukemia, Crohn's disease, hypertension, Myelodysplastic syndrome and prostate cancer and others. Natco Pharma offers active pharmaceutical ingredients (APIs) for the domestic and international markets. It manages five API and finished dosage facilities and a research center in India. The company operates in India, the US, Canada, and Europe. Natco Pharma is headquartered in Hyderabad, Telangana, India.

Natco Pharma Ltd Key Recent Developments

Aug 07,2017: Natco Pharma Announces Resignation of Directors
Aug 07,2017: NATCO Pharma Reports Financial Results For The Quarter Ended 30 June 2017
Jul 20,2017: NATCO receives establishment inspection report (EIR) from U.S. food and drug administration (FDA)
May 30,2017: NATCO records INR 2078.9 Crore total consolidated revenue and INR 486.0 Crore of profit, after tax, for the full year ended March 2017
Feb 14,2017: NATCO records INR 685.13 Crore total consolidated revenue and INR 194.76 Crore of profit, after tax, for the Third Quarter, FY 2017 14 February 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 - About the Company 6
Natco Pharma Ltd - Key Facts 6
Natco Pharma Ltd - Key Employees 7
Natco Pharma Ltd - Key Employee Biographies 8
Natco Pharma Ltd - Major Products and Services 9
Natco Pharma Ltd - History 10
Natco Pharma Ltd - Company Statement 12
Natco Pharma Ltd - Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Joint Venture 14
Section 2 – Company Analysis 15
Natco Pharma Ltd - Business Description 15
Natco Pharma Ltd - Corporate Strategy 16
Natco Pharma Ltd - SWOT Analysis 17
SWOT Analysis - Overview 17
Natco Pharma Ltd - Strengths 17
Natco Pharma Ltd - Weaknesses 18
Natco Pharma Ltd - Opportunities 19
Natco Pharma Ltd - Threats 20
Natco Pharma Ltd - Key Competitors 21
Section 3 – Company Financial Ratios 22
Financial Ratios - Capital Market Ratios 22
Financial Ratios - Annual Ratios 23
Performance Chart 26
Financial Performance 26
Financial Ratios - Interim Ratios 27
Financial Ratios - Ratio Charts 28
Section 4 – Company’s Lifesciences Financial Deals and Alliances 29
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 29
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 30
Natco Pharma Ltd, Recent Deals Summary 31
Section 5 – Company’s Recent Developments 32
Aug 07, 2017: NATCO Pharma Reports Financial Results For The Quarter Ended 30 June 2017 32
Aug 07, 2017: Natco Pharma Announces Resignation of Directors 33
Jul 20, 2017: NATCO receives establishment inspection report (EIR) from U.S. food and drug administration (FDA) 34
May 30, 2017: NATCO records INR 2078.9 Crore total consolidated revenue and INR 486.0 Crore of profit, after tax, for the full year ended March 2017 35
Feb 14, 2017: NATCO records INR 685.13 Crore total consolidated revenue and INR 194.76 Crore of profit, after tax, for the Third Quarter, FY 2017 14 February 2017 36
Jan 25, 2017: NATCO updates on USFDA inspection at its Kothur Formulation Facility 37
Nov 11, 2016: NATCO records INR 467.86 Crore operating revenue for the Second Quarter, FY 2017, ended September 2016 38
Aug 25, 2016: NATCO receives Establishment Inspection Report for Chennai facility 39
Aug 16, 2016: Natco Receives Establishment Inspection Report For Kothur Facility 40
Aug 09, 2016: Natco Pharma Announces First quarter Results for 2016 41
Section 6 – Appendix 42
Methodology 42
Ratio Definitions 42
About GlobalData 46
Contact Us 46
Disclaimer 46
List of Tables
Natco Pharma Ltd, Key Facts 6
Natco Pharma Ltd, Key Employees 7
Natco Pharma Ltd, Key Employee Biographies 8
Natco Pharma Ltd, Major Products and Services 9
Natco Pharma Ltd, History 10
Natco Pharma Ltd, Other Locations 13
Natco Pharma Ltd, Subsidiaries 13
Natco Pharma Ltd, Joint Venture 14
Natco Pharma Ltd, Key Competitors 21
Natco Pharma Ltd, Ratios based on current share price 22
Natco Pharma Ltd, Annual Ratios 23
Natco Pharma Ltd, Annual Ratios (Cont...1) 24
Natco Pharma Ltd, Annual Ratios (Cont...2) 25
Natco Pharma Ltd, Interim Ratios 27
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 29
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 30
Natco Pharma Ltd, Recent Deals Summary 31
Currency Codes 42
Capital Market Ratios 42
Equity Ratios 43
Profitability Ratios 43
Cost Ratios 44
Liquidity Ratios 44
Leverage Ratios 45
Efficiency Ratios 45List of Figures
Natco Pharma Ltd, Performance Chart (2013 - 2017) 26
Natco Pharma Ltd, Ratio Charts 28
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 29
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 30
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter